The case for routine use of adjuvant therapy in pancreatic cancer.

Kennedy EP, Yeo CJ. The case for routine use of adjuvant therapy in pancreatic cancer. J Surg Oncol. 2007 Jun 1; 95(7):597-603.

View in: PubMed

subject areas

Adenocarcinoma
Antineoplastic Combined Chemotherapy Protocols
Cancer Vaccines
Chemotherapy, Adjuvant
Clinical Trials as Topic
Combined Modality Therapy
Drug Administration Schedule
Fluorouracil
Granulocyte-Macrophage Colony-Stimulating Factor
Humans
Leucovorin
Pancreatectomy
Pancreatic Neoplasms
Radiotherapy Dosage
Radiotherapy, Adjuvant
Randomized Controlled Trials as Topic
Survival Rate

authors with profiles

Charles Yeo

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement